As evident in the development of Ammeltz, Sawaday, and other products, Kazumasa Kobayashi has been striving to develop new products since before he assumed the post of President. Kobayashi's policies have become even stronger after his appointment.

Such developments occurred not only at the company itself, but also in pursuing business tie-ups with overseas firms and enthusiastically establishing joint ventures. PoliDent and PoliGrip, which went on sale in 1970, and Corega, which started up in 1980, are all products of overseas firms.

What's more, "Medicon, Inc.", a joint corporation with C.R. Bard of the U.S., was established in 1972. In 1976, "Kobayashi Block Company, Ltd." was founded as a joint venture with Block Drug Company, Inc.

A substantial overseas strategy and expansion notwithstanding, there are few companies bearing fruit. Furthermore, although Kobayashi Pharmaceutical is a company noted in Japan for his trustworthiness and achievements in wholesale medical supply, the situation is different abroad.

However, if such things continue to be said, no headway will ever be made. The methods used by the President to secure business tie-ups and joint venture establishments resembled a salesman's dive into door-to-door sales. Single partnerships appeared thanks to the help of the right connections.

American corporations do not operate under the same custom of connection-influenced business as does Japan. Even under favorable conditions, the original partner will still respond to transactions. President Kobayashi and Managing Director Miyata fought together with partners in this way on many occasions and gained their trust.

The successes of Kobayashi Block had great significance for the company's future overseas strategy. With marketing as their priority, Kobayashi's top leaders and sales force received high marks overseas.

And while not much as materialized from these efforts concretely, contracted product exchanges have enjoyed 100% success. These achievements also reached overseas when inquiries and orders began pouring into the New York Office and the head office. In addition, sales have been skyrocketing from overseas as well. Plants and equipment were reduced by the start-up of such product operations headquarters. To overcome this, the Shiga Plant was established in March 1970. And in May 1983, the most substantial time of this period, "Toyama Kobayashi Pharmaceutical, Inc." (Toyama Plant) was founded in Osawano-machi, Kaminiikawa-gun, in Toyama Prefecture, paving the way for the production of Sawaday and other products.

The Kobayashi Pharmaceutical group was also strengthened further by the goodwill acquisition of Kobayashi Noko in March 1985.